Financial News
Regeneron Pharmaceuticals (NQ: REGN )
957.00
+19.39
(+2.07%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Headline News about Regeneron Pharmaceuticals
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Check Out What Whales Are Doing With REGN
September 08, 2023
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
September 05, 2023
Via Benzinga
Via Benzinga
Check Out What Whales Are Doing With REGN
August 25, 2023
Via Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
August 22, 2023
Via Benzinga
18 Analysts Have This to Say About Regeneron Pharmaceuticals
August 16, 2023
Via Benzinga
Via Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
August 14, 2023
Via Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
Via Benzinga
Exposures
Product Safety
Value Stocks Outshine Growth Amidst Rising Treasury Yields: Key Sectors and Stocks Analyzed
August 21, 2023
Via Benzinga
Topics
ETFs
FDA Approves Regeneron's Drug For Ultra Rare Immune Disorder
August 21, 2023
Via Benzinga
Exposures
Product Safety
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
August 21, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.